Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China flag China · Delayed Price · Currency is CNY
6.17
+0.26 (4.40%)
At close: Mar 10, 2026

SHA:688373 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Market Capitalization
4,0493,9603,2374,2795,805-
Upgrade
Market Cap Growth
13.18%22.34%-24.35%-26.30%--
Upgrade
Enterprise Value
3,9303,8412,8003,4434,701-
Upgrade
Last Close Price
6.176.044.946.538.86-
Upgrade
PS Ratio
28.5627.9324.8547.13120.42-
Upgrade
PB Ratio
15.7215.387.375.134.78-
Upgrade
P/TBV Ratio
15.7915.447.405.144.79-
Upgrade
EV/Sales Ratio
27.7227.0921.5037.9397.53-
Upgrade
Debt / Equity Ratio
1.421.420.690.270.190.37
Upgrade
Net Debt / Equity Ratio
-0.46-0.46-0.66-0.88-0.86-0.71
Upgrade
Net Debt / EBITDA Ratio
0.490.490.671.674.061.16
Upgrade
Net Debt / FCF Ratio
--0.652.174.121.53
Upgrade
Asset Turnover
--0.130.070.050.01
Upgrade
Inventory Turnover
--0.500.560.540.09
Upgrade
Quick Ratio
--3.057.1411.135.03
Upgrade
Current Ratio
--3.537.7211.915.41
Upgrade
Return on Equity (ROE)
-69.38%-69.38%-69.24%-41.12%-26.66%-42.75%
Upgrade
Return on Assets (ROA)
---27.18%-20.63%-15.00%-25.55%
Upgrade
Return on Capital Employed (ROCE)
---68.90%-42.60%-18.60%-48.60%
Upgrade
Earnings Yield
-5.97%-6.10%-13.62%-9.84%-3.79%-
Upgrade
FCF Yield
---13.84%-7.87%-4.34%-
Upgrade
Buyback Yield / Dilution
0.40%0.40%--13.09%-10.17%-106.16%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.